Equator Beverage (MOJO) 10-K 22 Mar 24 2023 FY Annual report Financial data

Cover

Cover - USD ($)	12 Months Ended
	Dec. 31, 2023	Mar. 22, 2024	Jun. 30, 2023
Cover [Abstract]
Entity Registrant Name	EQUATOR Beverage Company
Entity Central Index Key	0001414953
Document Type	10-K
Amendment Flag	false
Entity Voluntary Filers	No
Current Fiscal Year End Date	--12-31
Entity Well Known Seasoned Issuer	No
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Document Period End Date	Dec. 31, 2023
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2023
Entity Common Stock Shares Outstanding		17,134,346
Entity Public Float			$ 1,443,842
Document Annual Report	true
Document Transition Report	false
Document Fin Stmt Error Correction Flag	false
Entity File Number	000-55269
Entity Incorporation State Country Code	DE
Entity Tax Identification Number	26-0884348
Entity Address Address Line 1	185 Hudson Street
Entity Address Address Line 2	Floor 25
Entity Address City Or Town	Jersey City
Entity Address State Or Province	NJ
Entity Address Postal Zip Code	07302
City Area Code	929
Auditor Name	Victor Mokuolu, CPA PLLC
Auditor Location	Houston, Texas
Auditor Firm Id	6771
Local Phone Number	264 7944
Security 12g Title	Common Stock, $0.001 par value per share
Entity Interactive Data Current	Yes

Statements of Operations

Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Statements of Operations
Revenue	$ 2,288,272	$ 1,821,492
Cost of Revenue	1,276,411	1,190,536
Gross Profit	1,011,861	630,956
Operating Expenses
Selling, general and administrative	1,175,478	859,155
Total Operating Expenses	1,175,478	859,155
Loss from operations	(163,617)	(228,199)
Interest Expense	(13,099)	(10,637)
Loss Before Provision for Income Taxes	(176,716)	(238,836)
Provision for Income Taxes	(54,018)	0
Benefit from Deferred Tax Asset	50,777	0
Net Loss	$ (179,957)	$ (238,836)
Net Loss Per Common Share, Basic and Diluted	$ (0.01)	$ (0.02)
Weighted Average Number of Common Shares Outstanding, Basic and Diluted	16,660,452	15,841,585

Balance Sheets

Balance Sheets - USD ($)	Dec. 31, 2023	Dec. 31, 2022
CURRENT ASSETS:
Cash and cash equivalents	$ 87,339	$ 10,738
Accounts receivable, net	135,061	93,852
Inventory	270,788	268,289
Supplier deposits	52,655	44,772
Prepaid expenses	35,650	23,468
Total Current Assets	581,493	441,119
TOTAL ASSETS	581,493	441,119
CURRENT LIABILITIES:
Accounts payable and accrued expenses	80,621	70,252
Related party loans	230,000	225,000
Total Current Liabilities	310,621	295,252
STOCKHOLDERS' EQUITY
Common stock, 20,000,000 shares authorized at $0.001 par value, 16,933,346 and 16,230,615 shares issued and outstanding, at December 31, 2023 and December 31, 2022, respectively	16,934	16,231
Additional paid-in capital	24,063,176	23,758,917
Accumulated deficit	(23,809,238)	(23,629,281)
Total Stockholders' Equity	270,872	145,867
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 581,493	$ 441,119

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2023	Dec. 31, 2022
Balance Sheets
Common stock, shares authorized	20,000,000	20,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares issued	16,933,346	16,230,615
Common stock, shares outstanding	16,933,346	16,230,615

Statements of Changes in Stockh

Statements of Changes in Stockholders' Equity - USD ($)	Total	Common Stock	Additional Paid-In Capital	Retained Earnings (Accumulated Deficit)
Balance, shares at Dec. 31, 2021		15,548,903
Balance, amount at Dec. 31, 2021	$ 370,553	$ 15,549	$ 23,745,449	$ (23,390,445)
Restricted, Non-trading Stock Issued to Directors and Employees, shares		1,353,000
Restricted, Non-trading Stock Issued to Directors and Employees, amount	181,889	$ 1,353	180,536	0
Exercise of Stock Options, shares		159,054
Exercise of Stock Options, amount	25,449	$ 159	25,290
Stock Retired to Treasury, shares		(830,342)
Stock Retired to Treasury, amount	(193,188)	$ (830)	(192,358)	0
Net Loss	(238,836)	$ 0	0	(238,836)
Balance, shares at Dec. 31, 2022		16,230,615
Balance, amount at Dec. 31, 2022	145,867	$ 16,231	23,758,917	(23,629,281)
Restricted, Non-trading Stock Issued to Directors and Employees, shares		1,104,000
Restricted, Non-trading Stock Issued to Directors and Employees, amount	356,776	$ 1,104	355,672	0
Stock Retired to Treasury, shares		(401,269)
Stock Retired to Treasury, amount	(51,814)	$ (401)	(51,413)	0
Net Loss	(179,957)	$ 0	0	(179,957)
Balance, shares at Dec. 31, 2023		16,933,346
Balance, amount at Dec. 31, 2023	$ 270,872	$ 16,934	$ 24,063,176	$ (23,809,238)

Statements of Cash Flows

Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash Flows from Operating Activities:
Net loss	$ (179,957)	$ (238,836)
Adjustments to Reconcile Net Loss to Net Cash Provided by/ ( Used in) Operating Activities:
Restricted, Non-trading Common Stock Issued to Directors and Employees	356,776	181,889
Changes in Assets and Liabilities:
(Increase) / decrease in accounts receivable	(41,209)	14,783
Increase in inventory	(2,499)	(33,723)
Increase in supplier deposits	(7,883)	(16,772)
Increase in prepaid expenses	(12,182)	(11,653)
Increase in accounts payable and accrued expenses	10,369	11,308
Net Cash Provided by / (Used) in) Operating Activities	123,415	(93,004)
Net Cash Provided by/ (Used in) Financing Activities:
Proceeds from related party loan	230,000	510,000
Repayments to related party loan	(225,000)	(285,000)
Proceeds from stock option exercise	0	25,449
Shares repurchased for cancellation	(51,814)	(193,188)
Net Cash (Used in)/ Provided by Financing Activities	(46,814)	57,261
Net Increase / (Decrease) in Cash and Cash Equivalents	76,601	(35,743)
Cash and Cash Equivalents at Beginning of Period	10,738	46,481
Cash and Cash Equivalents at End of Periods	87,339	10,738
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash Paid for Interest	$ 13,100	$ 10,641

BUSINESS

BUSINESS	12 Months Ended
	Dec. 31, 2023
BUSINESS
BUSINESS	NOTE 1 – BUSINESS Overview EQUATOR Beverage Company, headquartered in Jersey City, NJ, is a Delaware corporation that specializes in developing, producing, distributing, and marketing new beverage products. Our beverages have been certified Non-GMO Project Verified and USDA Organic, and we offer both nonalcoholic and ready-to-drink alcoholic options. In addition, we have a line of sparkling energy beverages targeted towards female consumers. Our beverages can be found in North America, the Caribbean, and Bermuda. We are committed to sustainability and use 100% recyclable, eco-friendly packaging that has a minimal impact on the environment. Furthermore, our products are plant-based, renewable, and eco-friendly.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Use of Estimates The financial statements are prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”). Management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents Cash equivalents include investment instruments and time deposits purchased with a maturity of three months or less. As of December 31, 2023, and December 31, 2022, the Company did not have any cash equivalents. Accounts Receivable Accounts receivable is stated at the amount management expects to collect from outstanding balances. The Company provides for probable uncollectible amounts based upon its assessment of the current status of the individual receivables and after using reasonable collection efforts. The allowance for doubtful accounts as of December 31, 2023 and 2022 was zero. Inventory Inventory, consisting solely of finished goods, are stated at the lower of cost (first-in, first-out method) or net realizable value (“NRV”). If necessary, the Company provides allowances to adjust the carrying value of its inventories to NRV when NRV is below cost. There were no such adjustments in 2023 or 2022. Revenue Recognition Revenue from sales of products is recognized when the related performance obligation is satisfied. The Company’s performance obligation is satisfied upon the shipment or delivery of products to customers. The Company’s products are sold on cash and credit terms which are established in accordance with standardized industry practices and typically require payment within 30 days of delivery. Shipping and Handling Costs Shipping and Handling Costs incurred to move finished goods from our sales distribution centers to customer locations are included in the line Selling, General and Administrative Expenses in our Statements of Operations. Net Loss Per Common Share The Company computes per share amounts in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 260, “ Income Taxes The Company provides for income taxes using the asset and liability approach in accounting for income taxes. Deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax bases of assets and liabilities and the tax rates in effect when these differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance if, based on the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. The Company did not have a deferred tax liability at December 31, 2023 and 2022. As of December 31, 2023, and December 31, 2022, the Company had no accrued interest or penalties. The Company had no Federal or State tax examinations in the past nor does it have any at the current time. The table below shows the details of the Net Operating Loss Carryforward and Deferred Tax Assets for 2023 and 2022: 2023 2022 Net Operating Loss Carryforward, January 1 $ 3,796,573 $ 3,739,625 (Taxable Income)/ Net Loss, January 1 to December 31 (180,060 ) 56,948 Net Operating Loss Carryforward, December 31 $ 3,616,513 $ 3,796,573 Federal Deferred Tax Asset, January 1 797,280 785,321 Federal Tax Expense as of December 31 (21% Tax Rate) (37,813 ) 11,959 Federal Deferred Tax Asset, December 31 $ 759,468 $ 797,280 State of New Jersey Deferred Tax Asset, January 1 341,107 336,254 State of New Jersey Tax Expense as of December 31 (9% Tax Rate) (16,205 ) 4,854 State of New Jersey Deferred Tax Asset, December 31 $ 324,902 S 341,107 Total Deferred Tax Asset, December 31 $ 1,084,370 $ 1,138,388 Total Tax Expense $ 54,018 - Fair value of financial instruments The carrying amounts of financial instruments, which include cash, accounts receivable, accounts payable and accrued expenses approximate their fair values due to their short-term nature.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Dec. 31, 2023
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES	NOTE 3 – COMMITMENTS AND CONTINGENCIES Employment Agreements Pursuant to the Amended and Restated Employment Agreement dated April 6, 2017 and amended on September 1, 2022, Mr. Simpson is paid a salary of $8,000 per month and 67,000 shares of restricted, non-trading common stock. The employment agreement expires on March 31, 2027. Pursuant to the Agreement, should Mr. Simpson’s employment be terminated without cause, the Company is obligated to pay Mr. Simpson all amounts from the contract immediately for the remaining term of 39 months. At December 31, 2023, the potential liability to EQUATOR Beverage Company was $312,000 and 2,613,000 shares of restricted, non-trading common stock.

STOCKHOLDERS EQUITY

STOCKHOLDERS EQUITY	12 Months Ended
	Dec. 31, 2023
STOCKHOLDERS EQUITY
STOCKHOLDERS' EQUITY	NOTE 4 – STOCKHOLDERS’ EQUITY On July 5, 2022, the State of Delaware approved the 1-for-2 reverse split and the decrease in Authorized shares from 40,000,000 to 20,000,000 shares. On June 8, 2022, the Board of Directors of the Company approved a prospective amendment to the Fourth Article of the Company’s Articles of Incorporation to decrease the authorized common stock from 40,000,000 shares, par value $0.001, to 20,000,000 shares, par value $0.001. On June 8, 2022, the majority stockholders approved the decrease in authorized shares amendment by written consent, in lieu of a special meeting of the stockholders. On June 8, 2022, the Board of Directors of the Company approved the prospective amendment to the Company’s Articles of Incorporation to effect a 1-for-2 reverse split of the Company’s Common Stock. On June 8, 2022, stockholders of the Company owning a majority of the Company’s outstanding voting stock approved the reverse stock split by written consent, in lieu of a special meeting of the stockholders. The decrease in authorized shares and reverse stock split was approved by FINRA on July 19, 2022 and effective July 20, 2022. All share and per share data has been retroactively adjusted to reflect the reverse stock split Restricted Stock Issuances The table below summarizes the restricted, non-trading stock awards during the years 2023 and 2022: Restricted, Non-trading Stock Awards Officers and Directors January 1 to December 31 2023 2022 VWAP Shares Amount VWAP Shares Amount Q1 Q1 Glenn Simpson $ 0.06 201,000 $ 11,792 Glenn Simpson $ 0.20 450,500 $ 76,368 Diane Cudia $ 0.06 37,500 2,200 Diane Cudia $ 0.20 106,250 17,800 Jeffrey Devlin $ 0.06 37,500 2,200 Jeffrey Devlin $ 0.20 106,250 17,800 Total 276,000 $ 16,192 Total 663,000 $ 111,968 Q2 Q2 Glenn Simpson $ 0.10 201,000 $ 22,110 Glenn Simpson $ 0.16 100,500 $ 17,554 Diane Cudia $ 0.10 37,500 4,125 Diane Cudia $ 0.16 18,750 3,275 Jeffrey Devlin $ 0.10 37,500 4,125 Jeffrey Devlin $ 0.16 18,750 3,275 Total 276,000 $ 30,360 Total 138,000 $ 24,104 Q3 Q3 Glenn Simpson $ 0.45 201,000 $ 94,403 Glenn Simpson $ 0.12 201,000 $ 20,100 Jeffrey Devlin $ 0.45 37,500 17,613 Jeffrey Devlin $ 0.12 37,500 3,750 Total 238,500 $ 112,016 Total 238,500 $ 23,850 Q4 Q4 Glenn Simpson $ 0.63 201,000 $ 131,521 Glenn Simpson $ 0.06 201,000 $ 13,266 Diane Cudia $ 0.63 75,000 42,150 Diane Cudia $ 0.06 75,000 6,226 Jeffrey Devlin $ 0.63 37,500 $ 24,538 Jeffrey Devlin $ 0.06 37,500 $ 2,475 Total 313,500 $ 198,209 313,500 $ 21,967 Grand Total 1,104,000 $ 356,777 Grand Total 1,353,000 $ 181,889 On June 1, 2022, Mr. Simpson exercised his options to purchase 159,054 shares of restricted and non-trading shares at $0.16 per share. The total purchase price was $25,449. The stock closed at $0.16 on the exercise date. There were no options outstanding after this option exercise. Stock Purchased for Cancellation During the year ended December 31, 2023, the Company purchased 401,269 shares of its Common Stock from shareholders at a cost of $51,814. During the year ended December 31, 2022 the Company purchased 830,342 shares of its Common Stock from shareholders at a cost of $193,188.

STOCK OPTIONS

STOCK OPTIONS	12 Months Ended
	Dec. 31, 2023
STOCK OPTIONS
STOCK OPTIONS	NOTE 5 – STOCK OPTIONS As of December 31, 2023, there are no outstanding stock options and there was no obligation to issue stock options. On June 1, 2022, Mr. Simpson exercised options to purchase 159,054 shares of restricted and non-trading shares at $0.16 per share. The total purchase price was $25,449. The stock closed at $0.16 on the exercise date. There were no options outstanding after this option exercise. On February 4, 2022, the Company adjusted the exercise price of the options granted to Mr. Simpson from $0.32 per share to $0.16 per share. The stock closed at $0.17 on that day. During the years ended December 31, 2023 and 2022, compensation expense related to stock options was $0. As of December 31, 2023, there was no unrecognized compensation cost related to non-vested stock options.

CONCENTRATIONS

CONCENTRATIONS	12 Months Ended
	Dec. 31, 2023
CONCENTRATIONS
CONCENTRATIONS	NOTE 6 – CONCENTRATIONS Major Customers* During the year ended December 31, 2023, the Company had six customers that accounted for 90% of revenue. Accounts receivable at December 31, 2022 from these six customers amounted to $112,167. For the year ended December 31, 2022, there were five major customers accounting for 90% of total revenue. Major Suppliers* During the year ended December 31, 2023, the Company purchased its inventory from two suppliers. The Company has established relationships with other suppliers which management believes could meet its needs on similar terms. Accounts payable at December 31, 2023 to both suppliers were $25,480. *Disclosure of the specific revenues generated by each customer and purchases from each supplier would have the effect of revealing sensitive financial and commercial information and would unfairly expose confidential aspects of the Company’s business strategies. The Company believes that its current disclosure satisfies the requirements of ASC 275-10-50-16 through 20 and provides ample information regarding the nature of concentration risk.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	12 Months Ended
	Dec. 31, 2023
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS	NOTE 7 – RELATED PARTY TRANSACTIONS Mr. Simpson lent funds to the Company for a revolving loan with a principal amount up to $300,000. The loan bears a 6% simple interest per year. The principal and any accrued interest are due and payable on demand, and the Company has the right to pay back the loan in full or make payments without penalty. As of December 31, 2023, the loan payable to Mr. Simpson was $230,000. As of December 31, 2022, the loan payable to Mr. Simpson was $225,000. On June 1, 2022, Mr. Simpson exercised 159,054 stock options at an exercise price of $0.16. The Company issued 159,054 restricted and non-trading shares of common stock in exchange for the total purchase price of $25,449. The stock closed at $0.16 on the exercise date. There were no options outstanding after this option exercise.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Use of Estimates	The financial statements are prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”). Management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents	Cash equivalents include investment instruments and time deposits purchased with a maturity of three months or less. As of December 31, 2023, and December 31, 2022, the Company did not have any cash equivalents.
Accounts Receivable	Accounts receivable is stated at the amount management expects to collect from outstanding balances. The Company provides for probable uncollectible amounts based upon its assessment of the current status of the individual receivables and after using reasonable collection efforts. The allowance for doubtful accounts as of December 31, 2023 and 2022 was zero.
Inventory	Inventory, consisting solely of finished goods, are stated at the lower of cost (first-in, first-out method) or net realizable value (“NRV”). If necessary, the Company provides allowances to adjust the carrying value of its inventories to NRV when NRV is below cost. There were no such adjustments in 2023 or 2022.
Revenue Recognition	Revenue from sales of products is recognized when the related performance obligation is satisfied. The Company’s performance obligation is satisfied upon the shipment or delivery of products to customers. The Company’s products are sold on cash and credit terms which are established in accordance with standardized industry practices and typically require payment within 30 days of delivery.
Shipping and Handling Costs	Shipping and Handling Costs incurred to move finished goods from our sales distribution centers to customer locations are included in the line Selling, General and Administrative Expenses in our Statements of Operations.
Net Loss Per Common Share	The Company computes per share amounts in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 260, “
Income Taxes	The Company provides for income taxes using the asset and liability approach in accounting for income taxes. Deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax bases of assets and liabilities and the tax rates in effect when these differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance if, based on the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. The Company did not have a deferred tax liability at December 31, 2023 and 2022. As of December 31, 2023, and December 31, 2022, the Company had no accrued interest or penalties. The Company had no Federal or State tax examinations in the past nor does it have any at the current time. The table below shows the details of the Net Operating Loss Carryforward and Deferred Tax Assets for 2023 and 2022: 2023 2022 Net Operating Loss Carryforward, January 1 $ 3,796,573 $ 3,739,625 (Taxable Income)/ Net Loss, January 1 to December 31 (180,060 ) 56,948 Net Operating Loss Carryforward, December 31 $ 3,616,513 $ 3,796,573 Federal Deferred Tax Asset, January 1 797,280 785,321 Federal Tax Expense as of December 31 (21% Tax Rate) (37,813 ) 11,959 Federal Deferred Tax Asset, December 31 $ 759,468 $ 797,280 State of New Jersey Deferred Tax Asset, January 1 341,107 336,254 State of New Jersey Tax Expense as of December 31 (9% Tax Rate) (16,205 ) 4,854 State of New Jersey Deferred Tax Asset, December 31 $ 324,902 S 341,107 Total Deferred Tax Asset, December 31 $ 1,084,370 $ 1,138,388 Total Tax Expense $ 54,018 -
Fair value of financial instruments	The carrying amounts of financial instruments, which include cash, accounts receivable, accounts payable and accrued expenses approximate their fair values due to their short-term nature.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Dec. 31, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Schedule of Deferred Tax Assets	2023 2022 Net Operating Loss Carryforward, January 1 $ 3,796,573 $ 3,739,625 (Taxable Income)/ Net Loss, January 1 to December 31 (180,060 ) 56,948 Net Operating Loss Carryforward, December 31 $ 3,616,513 $ 3,796,573 Federal Deferred Tax Asset, January 1 797,280 785,321 Federal Tax Expense as of December 31 (21% Tax Rate) (37,813 ) 11,959 Federal Deferred Tax Asset, December 31 $ 759,468 $ 797,280 State of New Jersey Deferred Tax Asset, January 1 341,107 336,254 State of New Jersey Tax Expense as of December 31 (9% Tax Rate) (16,205 ) 4,854 State of New Jersey Deferred Tax Asset, December 31 $ 324,902 S 341,107 Total Deferred Tax Asset, December 31 $ 1,084,370 $ 1,138,388 Total Tax Expense $ 54,018 -

STOCKHOLDERS EQUITY (Tables)

STOCKHOLDERS EQUITY (Tables)	12 Months Ended
	Dec. 31, 2023
STOCKHOLDERS EQUITY
Schedule of Restricted Stock Awards	Restricted, Non-trading Stock Awards Officers and Directors January 1 to December 31 2023 2022 VWAP Shares Amount VWAP Shares Amount Q1 Q1 Glenn Simpson $ 0.06 201,000 $ 11,792 Glenn Simpson $ 0.20 450,500 $ 76,368 Diane Cudia $ 0.06 37,500 2,200 Diane Cudia $ 0.20 106,250 17,800 Jeffrey Devlin $ 0.06 37,500 2,200 Jeffrey Devlin $ 0.20 106,250 17,800 Total 276,000 $ 16,192 Total 663,000 $ 111,968 Q2 Q2 Glenn Simpson $ 0.10 201,000 $ 22,110 Glenn Simpson $ 0.16 100,500 $ 17,554 Diane Cudia $ 0.10 37,500 4,125 Diane Cudia $ 0.16 18,750 3,275 Jeffrey Devlin $ 0.10 37,500 4,125 Jeffrey Devlin $ 0.16 18,750 3,275 Total 276,000 $ 30,360 Total 138,000 $ 24,104 Q3 Q3 Glenn Simpson $ 0.45 201,000 $ 94,403 Glenn Simpson $ 0.12 201,000 $ 20,100 Jeffrey Devlin $ 0.45 37,500 17,613 Jeffrey Devlin $ 0.12 37,500 3,750 Total 238,500 $ 112,016 Total 238,500 $ 23,850 Q4 Q4 Glenn Simpson $ 0.63 201,000 $ 131,521 Glenn Simpson $ 0.06 201,000 $ 13,266 Diane Cudia $ 0.63 75,000 42,150 Diane Cudia $ 0.06 75,000 6,226 Jeffrey Devlin $ 0.63 37,500 $ 24,538 Jeffrey Devlin $ 0.06 37,500 $ 2,475 Total 313,500 $ 198,209 313,500 $ 21,967 Grand Total 1,104,000 $ 356,777 Grand Total 1,353,000 $ 181,889

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Net Operating Loss Carryforward, January 1, beginning	$ 3,796,573	$ 3,739,625
(Taxable Income)/ Net Loss, January 1 to December 31	(180,060)	56,948
Net Operating Loss Carryforward, December 31, ending	3,616,513	3,796,573
Federal Deferred Tax Asset, January 1, beginning	797,280	785,321
Federal Tax Expense as of December 31 (21% Tax Rate)	(37,813)	11,959
Federal Deferred Tax Asset, January 1, ending	759,468	797,280
State of New Jersey Deferred Tax Asset, January 1, beginning	341,107	336,254
State of New Jersey Tax Expense as of December 31 (9% Tax Rate)	(16,205)	4,854
State of New Jersey Deferred Tax Asset, December 31, ending	324,902	341,107
Total Deferred Tax Asset, December 31, ending	1,084,370	1,138,388
Total Tax Expense	$ 54,018	$ 0

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Narrative) - Glenn Simpson [Member] - Employment Agreements [Member] - USD ($)		12 Months Ended
	Sep. 01, 2022	Dec. 31, 2023
Monthly salary	$ 8,000
Number of shares of non trading, restricted common stock, shares	67,000
Non Trading Restricted Common Stock [Member]
Issuance of restricted and non-trading, amount		$ 312,000
Issuance of restricted and non-trading, shares		2,613,000
Loan payment term		39 months

STOCKHOLDERS EQUITY (Details)

STOCKHOLDERS EQUITY (Details) - USD ($)	3 Months Ended								12 Months Ended
	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Restricted stock no of share	313,500	238,500	276,000	276,000	313,500	238,500	138,000	663,000	1,104,000	1,353,000
Restricted stock issuances amount	$ 198,209	$ 112,016	$ 30,360	$ 16,192	$ 21,967	$ 23,850	$ 24,104	$ 111,968	$ 356,777	$ 181,889
Glenn Simpson [Member] | Restricted Stock [Member]
Volume weighted adjusted price per share	$ 0.63	$ 0.45	$ 0.10	$ 0.06	$ 0.06	$ 0.12	$ 0.16	$ 0.20
Restricted stock no of share	201,000	201,000	201,000	201,000	201,000	201,000	100,500	450,500
Restricted stock issuances amount	$ 131,521	$ 94,403	$ 22,110	$ 11,792	$ 13,266	$ 20,100	$ 17,554	$ 76,368
Diane Cudia [Member] | Restricted Stock [Member]
Volume weighted adjusted price per share	$ 0.63		$ 0.10	$ 0.06	$ 0.06		$ 0.16	$ 0.20
Restricted stock no of share	75,000		37,500	2,200	75,000		18,750	106,250
Restricted stock issuances amount	$ 42,150		$ 4,125	$ 37,500	$ 6,226		$ 3,275	$ 17,800
Jeffrey Devlin [Member] | Restricted Stock [Member]
Volume weighted adjusted price per share	$ 0.63	$ 0.45	$ 0.10	$ 0.06	$ 0.06	$ 0.12	$ 0.16	$ 0.20
Restricted stock no of share	37,500	37,500	37,500	37,500	37,500	37,500	18,750	106,250
Restricted stock issuances amount	$ 24,538	$ 17,613	$ 4,125	$ 2,200	$ 2,475	$ 3,750	$ 3,275	$ 17,800

STOCKHOLDERS EQUITY (Details Na

STOCKHOLDERS EQUITY (Details Narrative) - USD ($)				12 Months Ended
	Jul. 05, 2022	Jun. 08, 2022	Jun. 01, 2022	Dec. 31, 2023	Dec. 31, 2022	Jul. 04, 2022
Reverse stock split	1-for-2 reverse split	effect a 1-for-2 reverse split of the Company’s Common Stock.
Common stock shares authorized	20,000,000			20,000,000	20,000,000	40,000,000
Common stock par value				$ 0.001	$ 0.001
Stock repurchased during period shares				401,269
Stock repurchased and returned to Treasury				$ 51,814
Restricted Common Stock [Member]
Stock repurchased during period shares					830,342
Stock repurchased and returned to Treasury					$ 193,188
Board of Directors [Member]
Common stock shares authorized		40,000,000
Common stock par value		$ 0.001
Board of Directors [Member] | Minimum [Member]
Common stock shares authorized		20,000,000
Common stock par value		$ 0.001
Mr. Simpson [Member]
Issuance of restricted and non-trading, shares			159,054
Exercise price option to purchase			$ 0.16
Purchase price of restricted and non trading shares			$ 25,449
Exercise stock close price option to purchase			$ 0.16

STOCK OPTIONS (Details Narrativ

STOCK OPTIONS (Details Narrative) - USD ($)			12 Months Ended
	Jun. 01, 2022	Feb. 04, 2022	Dec. 31, 2023	Dec. 31, 2022
Exercise price			$ 0.16
Exercise of stock options purchase price				$ 25,449
Share-based compensation expense			$ 0	$ 0
Glenn Simpson [Member] | Restricted and Non Trading Shares [Member]
Stock issued during period shares stock options exercised	159,054
Exercise price	$ 0.16	$ 0.17
Exercise of stock options purchase price	$ 25,449		$ 25,449
Glenn Simpson [Member] | Equity Option [Member]
Stock issued during period shares stock options exercised	159,054
Maximum [Member] | Glenn Simpson [Member]
Exercise price		0.32
Minimum [Member] | Glenn Simpson [Member]
Exercise price		$ 0.16

CONCENTRATIONS (Details Narrati

CONCENTRATIONS (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Major Customer [Member]
Percentage of Revenue major customer	90%	90%
Account receivable from six customer		$ 112,167
Major Suppliers [Member]
Account payable from two supplier	$ 25,480

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)			12 Months Ended
	Jun. 01, 2022	Feb. 04, 2022	Dec. 31, 2023	Dec. 31, 2022
Exercise price			$ 0.16
Exercise of stock options				$ 25,449
Glenn Simpson [Member] | Restricted and Non Trading Shares [Member]
Stock issued during period shares stock options exercised	159,054
Exercise price	$ 0.16	$ 0.17
Exercise of stock options	$ 25,449		$ 25,449
Glenn Simpson [Member] | Equity Option [Member]
Stock issued during period shares stock options exercised	159,054
Mr. Simpson [Member]
Loan payable			230,000	$ 225,000
Revolving loan principal amount			$ 300,000
Loan bears interest rate			6%